Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma
Dario Callegaro(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro Gronchi(University of Milan), Hans Gelderblom(Leiden University Medical Center), Rebecca A. Gladdy(Lunenfeld-Tanenbaum Research Institute), Rick L. Haas(Leiden University), Deanna Ng(Mount Sinai Hospital), Chandrajit P. Raut(Brigham and Women's Hospital), Sylvie Bonvalot(Institut Curie), D. Strauß(Royal Marsden Hospital), Sandrine Marréaud(European Organisation for Research and Treatment of Cancer), Charles Honoré(Institut Gustave Roussy), Aisha Miah(Institute of Cancer Research), Claudia Sangalli(Fondazione IRCCS Istituto Nazionale dei Tumori), Winan J. van Houdt(Diakonessenhuis hospital), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Mark Fairweather(Brigham and Women's Hospital), Eberhard Stoeckle(Institut Bergonié), Saskia Litière(European Organisation for Research and Treatment of Cancer), Andrew Hayes(Royal Marsden NHS Foundation Trust), Peter Chung(Princess Margaret Cancer Centre), Taiwo Ajayi(European Organisation for Research and Treatment of Cancer), Elizabeth H. Baldini(Dana-Farber Cancer Institute), Dimitri Tzanis(Université Paris Sciences et Lettres), Magali Fau(University of Toronto), Carol J. Swallow(Princess Margaret Cancer Centre)
Cited by 138
Related Papers
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k